開開實業(600272.SH)再次説明:公司沒有任何國家保密醫藥配方,也沒有六神丸的生產業務
格隆匯1月6日丨開開實業(600272.SH)發佈股票交易異常波動公吿,2022年1月5日,公司公佈了《2021年年度業績預增公吿》,公司本次業績預增大部分來源於非經營性損益,不具有持續性。類似此次專項政府補助以及綜合改革成本的支出皆是非經常性發生的,僅對當期淨利潤產生影響。
就近期市場傳聞公司全資子公司上海雷允上藥業西區有限公司六神丸的國家保密配方情況,公司再次説明如下:公司沒有任何國家保密醫藥配方,也沒有六神丸的生產業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.